Myriad genetics win on gene patent ownership is appealed

March 5, 2013

Myriad Genetics Inc. (MYGN)’s Australian court victory recognizing its ownership of patents for genes linked to cancer risks will be appealed by a group representing cancer patients, a law firm said. (Bloomberg)